Abstract
| Hot Topics in Primary Care: Individualizing Pharmacologic Management of Irritable Bowel Syndrome Kuritzky L1. J Fam Pract. 2015 Dec;64(12 Suppl):S16-21. |
| Author information 1Clinical Assistant Professor Emeritus, Department of Community Health and Family Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. Abstract The ill-defined pathogenesis of IBS, lack of a biomarker for the disease, and no universally agreed definition can make diagnosis challenging. Nonetheless, IBS is not a diagnosis of exclusion and is based on the signs and symptoms consistent with ROME III criteria, and the absence of signs indicative of other abdominal pathology. |
© Copyright 2013-2025 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.
